Clinical Trial Update: SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study of SAL-0951 for chemotherapy-induced anemia in patients with non-myeloid malignancies is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia

Drugs mentioned

• SAL-0951

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Anemia | Phase 2 | Status: RECRUITING